Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
For commercial invoices you often get 90 days payment.
Those words in second tranche are there to muddy the water and extend the obscurity to make things seem better. 90 days into July for a comment could let you say Oct but that’s not the 20 months.
But hey you cannot tell a know it all can you now especially an ex teacher.
The First Subscription Shares will rank pari passu with the existing Ordinary Shares and application has been made to the London Stock Exchange for admission of the First Subscription Shares and the First Value Payment Shares (as defined below) to trading on the Standard Segment of the Official List and the Main Market of the London Stock Exchange ("Admission"). The First Subscription is conditional, inter alia, on Admission and there being: (i) no breach of certain customary warranties given by the Company to Lanstead at any time prior to Admission; and (ii) no force majeure event occurring prior to Admission. Admission and dealings in the First Subscription Shares and the First Value Payment Shares is expected to commence at 8.00am on 17 December 2021.
Let’s also talk some more nonsense according to these experts here that cannot answer the facts but fling insults against real questions.
The raise of £70,000 was limited due to Main Market rules of maximum allowed if you include the freebie’s they gave in warrants to try get any kind of interest at 0.2p without an EAGM.
Now it gets them to the AGM!!
But of course this is attacked by this that are choosing to ignore the reality of the situation they rushed back into.
Especially one of those mud slingers there that was trashing this share for two years solid.
Looks like fair few stuck here with their pants down with the door not opening and the AGM approaching.
Ooohhh
And for those that are wishing Lanstead gone. Just remember it’s only because of Lanstead this hasn’t gone bankrupt yet.
Now that this is ending as we speak, where does further funds come from.
Just to add management will never tell you the real picture as to put fear into the investment community causing panic.
But
Let’s put it this way they raised £70,000 because they had to to see them to the AGM. Well guess what’s happening in less than two months time!!!!
Careful now as there are some ignorant people spouting ignorance to many.
20 months from ehehehum
“Admission. Admission and dealings in the First Subscription Shares and the First Value Payment Shares is expected to commence at 8.00am on 17 December 2021. ”
“
Once Lanstead have finished clearing to pay NFX by selling the SP will crash further as it’s been purposely held up to offload their A trades at near to the buy price. Been so manipulated to hold this up.
When that support goes as the MM’s we’re making cash out the set trades it will be turned off and the SP will then be manipulated further down as no support.
As I say.
Money tap is now turning off as Lanstead leave the building.
Where does the income come from the virtual business to keep their virtual salaries paid? Accounts, broker, legal team plus business trips to try get a business.
It’s not a good place to be in this climate as pharmaceuticals are actually holding back. Maybe next year but in the meantime you, me and I have to take another dilution hit which as mentioned should been done last year to keep this going till end next year.
Now 500,000 cash raised here is going to hurt. 40% dilution incoming but of course if and when they find a partner they will pay a few mil but nothing mega that is for sure.
As I said nothing this year or more importantly before reserves need boosting.
I’d say AGM fresh round September. No deal coming anytime soon if significance and the cash cow ends next month. So Lanstead run out but then we don’t really know who sold and selling from last round. Guess they will be taking up more again.
No
That’s before it failed on rats as a stand-alone treatment for IPF. Durability after heavy dosing failed
It got pulled they then changed tact to a SOC lesser treatment with some very basic sliver of lung tissue in a petri dish like they did in 2019 data. It’s moved backwards and the coffers are empty NXP001 locked permanently away for £50,000 k and NXP004 May reduce quantity of white powder usage and no money to move it, nobody interested and money nearly out.
Tick rock muggins o’clock
All sucked into Lala land.
It’s only part finished pre clinical not phase 1 ready and only for SOC not standalone. No chance, I repeat no chance this year and they need cash!!!! So hold and dilute ready for a potential sale but be sometime yet and the cash cow Lanstead empties soon ding a ling
What’s to hide? Don’t they trust them?
Have they doubts about anything coming from this? Quick in and out with potential freebie’s if by chance they can secure some early interest at this early stage of preclinical?
People trotting about as if this is now a given. It’s miles away from being proven and as mentioned before they have a problem after the rat data. That showed issues with durability in a living organism and that’s an issue. Drops onto a slice of lung tissue in a Petri dish is all well and good but this clashes with rats breathing in this exact powdered cocrystal formula at very low levels then at very high levels and then it was pulled!!! Why did they stop the tests before announcing the data when they had another go when it was already well underway?
They spent in excess of a million doing that rat data.
To then stop after previous fails and rebrand it as new SOC treatment which we already understood from the data Chris Blackwell announced end 2020!
It’s got something lurking in the background hence why the placing holder is hiding to avoid mud on their face if it fails.